iwNHL 2015 | iwNHL 2015 roundtable: Biology of diffuse large B-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Catherine M. Bollard, MBChB, MD, FRACP, FRCPA, of Children’s National Health System and The George Washington University, Washington, DC, chairs a discussion with Wyndham Wilson, MD, PhD, of the National Cancer Institute, Bethesda, MD, Louis M. Staudt, MD, PhD, of the National Cancer Institute, Bethesda, MD, and Riccardo Dalla-Favera, MD, of the Institute of Cancer Genetics, Columbia University, New York, NY, on the clinical implications of the current understanding of the biology of B cells and diffuse large B-cell lymphoma (DLBCL) subtypes, including activated B-cell-like (ABC) DLBCL and germinal-center B-cell-like (GCB) DLBCL. They explain that these subtypes are characterised by significant differences in outcomes and responses to treatment.
